Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News InnovAge Holding Corp INNV

Healthcare Drug Manufacturers - Major

InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly... see more

Add To Watchlist

Recent & Breaking News (NDAQ:INNV)

SECFilings.com: FDA Decision on FlutiCare Nears for Innovus Pharmaceuticals (INNV)

Marketwired July 12, 2016

Innovus Pharmaceuticals Well Capitalized With the Closing of $1.5M in Financing From Institutional Investors

Marketwired July 6, 2016

Innovus Pharmaceuticals Eliminates Over $1.8M in Liabilities

Marketwired June 15, 2016

Innovus Pharmaceuticals Announces Successful Top Line Results From RecalMax in Memory, Processing Speed and Thought Maintenance

Marketwired June 13, 2016

Innovus Pharma (INNV)'s Vesele Could Be the Best Complementary Product for Viagra and Cialis's $3.2 Billion Dollar Erectile Dysfunction Market

Marketwired June 9, 2016

Innovus Pharma Announces the Filing of the Product Licenses for Zestra, Zestra Glide, EjectDelay and Sensum+ With the Indian FDA (Directorate General of Health Services) by Its Partner Khandelwal Laboratories

Marketwired June 7, 2016

Innovus Pharma to Request Regulatory Guidance for Filing for Its FlutiCare Product in Europe for the Treatment of Allergic Rhinitis

Marketwired June 2, 2016

Innovus (INNV) Brings Leading Nasal Steroid From Rx to OTC

Marketwired June 1, 2016

Innovus Pharma Achieves Major Milestone With Securing a Manufacturing Agreement for FlutiCare in Anticipation of the FDA Decision

Marketwired May 31, 2016

Innovus Pharma Signs Exclusive License and Distribution Agreement With BroadMed for EjectDelay in Lebanon

Marketwired May 25, 2016

Innovus Pharma Joins AbbVie Inc. and Eli Lilly & Co. in the Race for the $3 Billion Testosterone Replacement Market

Marketwired May 24, 2016

SeeThruEquity Issues Update Note on Innovus Pharmaceuticals, Inc. (OTCQB: INNV) with a Price Target of $0.91

Accesswire May 23, 2016

Innovus Pharma CEO Provides Shareholder Update and Conference Call

Marketwired May 20, 2016

What an NYSE-MKT Uplisting Means for OTC Companies Like Innovus Pharma (INNV)

Marketwired May 18, 2016

Upcoming PDUFA and ANDA Approval Dates Could Catalyze Innovus Pharma (INNV) and Lipocine (LPCN)

Marketwired May 16, 2016

Innovus Pharma (INNV): Targeting $3+ Billion Markets With 13 Commercial Products

Marketwired May 11, 2016

SeeThruEquity Issues Update Note on Innovus Pharmaceuticals, Inc. (OTCQB: INNV) with a Price Target of $0.80

Accesswire April 19, 2016

Innovus Pharma CEO Provides Shareholder Update

Marketwired April 4, 2016

Innovus Pharma CEO Interviewed on CEOLIVE.Tv

Marketwired March 22, 2016

Innovus Pharma Announces the Availability of Androferti in the U.S.

Marketwired March 17, 2016